Market
How will major COVID-19 vaccine manufacturers respond to the Florida grand jury report by mid-2025?
2
Resolution / Starting Odds
Acknowledge issues and propose changes • 25%
Deny allegations and defend actions • 25%
No official response • 25%
Other • 25%
Official statements or press releases from the companies involved
Story
Florida Grand Jury Finds No Criminality, Highlights Deceptive Practices in 150-Page COVID-19 Vaccine Report
Jan 7, 2025, 09:02 PM
A Florida statewide grand jury, convened at the request of Governor Ron DeSantis in 2022, has released its 150-page final report on the investigation into COVID-19 vaccine manufacturers and their production processes. The report, unsealed on Tuesday, found no evidence of criminal activity but highlighted 'profound and serious issues' regarding vaccine development and safety monitoring in the United States. The grand jury criticized pharmaceutical companies and regulators for engaging in 'deceptive and obfuscatory behavior,' including allegedly hiding adverse effects of the vaccines from the public. It also made policy recommendations, such as increasing transparency in clinical trials and banning certain lobbying practices related to pharmaceutical drugs. The investigation was initiated as DeSantis bolstered his national profile ahead of his bid for the Republican Party's presidential nomination.
View original story
Similar markets
Legal action • 25%
Acknowledgement • 25%
Denial • 25%
No comment • 25%
Support the proposal • 25%
Other response • 25%
Remain neutral • 25%
Oppose the proposal • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Less favorable • 25%
More favorable • 25%
Uncertain • 25%
No change • 25%
Issue joint statement • 25%
Some issue statements • 25%
All issue statements • 25%
None issue statements • 25%
Positive impact • 25%
Investigation not concluded • 25%
Significant negative impact • 25%
No significant impact • 25%
Mostly negative • 25%
Mostly positive • 25%
Mixed • 25%
Indifferent • 25%
Guideline updates • 25%
Vaccine suspension or recall • 25%
No significant action • 25%
Further studies commissioned • 25%
Rejection of changes • 25%
No official stance • 25%
Calls for further review • 25%
Approval of changes • 25%
